Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04390776 · ClinicalTrials.gov registry record · Phase 1
Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 164
- Enrollment target
NCT04390776 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 164 participants.
The verdict
NCT04390776, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 164 participants
- Enrollment target
Study Summary
The study will be conducted as a Phase 1, open-label, single-dose, randomized, 2- or 3 period, cross over design in a single cohort.
Interventions
- DRUG PF-06651600
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2021-07-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04390776
The ClinicalTrials.gov registry entry for NCT04390776 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PF-06651600 is the first listed.
NCT04390776 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04390776 about?
NCT04390776 is a clinical study titled "Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.". The study will be conducted as a Phase 1, open-label, single-dose, randomized, 2- or 3 period, cross over design in a single cohort.
What is the current status of trial NCT04390776?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 164 participants. The study started on 2020-09-28. Estimated completion is 2021-07-19.
What interventions are being tested in trial NCT04390776?
The interventions under investigation include: PF-06651600 (DRUG).
Who is sponsoring clinical trial NCT04390776?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.